Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-019011
Filing Date
2025-02-12
Accepted
2025-02-12 17:18:42
Documents
129
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alks-20241231.htm   iXBRL 10-K 5601623
2 EX-4.1 alks-ex4_1.htm EX-4.1 107526
3 EX-19.1 alks-ex19_1.htm EX-19.1 81028
4 EX-21.1 alks-ex21_1.htm EX-21.1 17524
5 EX-23.1 alks-ex23_1.htm EX-23.1 3463
6 EX-31.1 alks-ex31_1.htm EX-31.1 18633
7 EX-31.2 alks-ex31_2.htm EX-31.2 18639
8 EX-32.1 alks-ex32_1.htm EX-32.1 22449
9 GRAPHIC img77546233_0.jpg GRAPHIC 90492
10 GRAPHIC img77546233_1.jpg GRAPHIC 134869
11 GRAPHIC img77546233_2.jpg GRAPHIC 140207
12 GRAPHIC img77546233_3.jpg GRAPHIC 66302
13 GRAPHIC img77546233_4.jpg GRAPHIC 131348
  Complete submission text file 0000950170-25-019011.txt   24298175

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20241231.xsd EX-101.SCH 2421728
132 EXTRACTED XBRL INSTANCE DOCUMENT alks-20241231_htm.xml XML 5368149
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35299 | Film No.: 25616093
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)